Business

Share Buy-Back

Share Buy-Back.

articleEkf Diagnostics Holdings PlcNovember 14, 20184/company/ekf-diagnostics-holdings-plc/news/share-buy-back-24
Share Buy-Back

About this update from Ekf Diagnostics Holdings Plc

[{"type":"text","content":"\n \nRNS Number : 3692H EKF Diagnostics Holdings PLC 14 November 2018  \n\nNOT FOR RELEASE, PUBLICATION OR DISTRIBUTION, IN WHOLE OR IN PART, DIRECTLY OR INDIRECTLY, TO US PERSONS OR IN OR INTO THE UNITED STATES, CANADA, AUSTRALIA, THE REPUBLIC OF SOUTH AFRICA, THE REPUBLIC OF IRELAND, JAPAN OR ANY JURISDICTION IN WHICH THE SAME WOULD BE UNLAWFUL.\nTHIS ANNOUNCEMENT CONTAINS INSIDE INFORMATION WITHIN THE MEANING OF THE MARKET ABUSE REGULATION (EU) (NO 596/2014) WHICH FOLLOWING THE RELEASE OF THIS ANNOUNCEMENT CEASES TO BE INSIDE INFORMATION.\n \nEKF Diagnostics Holdings plc\n(\"EKF\" or the \"Company\")\n \nShare Buy-Back\n \nEKF Diagnostics Holdings plc (AIM: EKF), the AIM-traded medical diagnostics business, is pleased to announce that it intends to conduct on-market purchases under a share buy-back programme to repurchase up to 7,500,000 ordinary shares of £0.01 each in the capital of the Company (the \"Ordinary Shares\"), pursuant to the authority obtained at the Company's most recent annual general meeting held on 8 May 2018 (the \"Buy-Back\"). If fully executed, the Buy-Back would return a maximum £2.1 million (before expenses) to shareholders of the Company. The Buy-Back will be funded from the Company's existing cash resources and any Ordinary Shares re-purchased will be cancelled.  Repurchases may be made up to and including 14 December 2018. \n \nThe Company will repurchase up to a maximum of 7,500,000 Ordinary Shares, representing up to approximately 1.64 per cent. of the Company's issued share capital, provided that any and all buybacks will be made at a price per Ordinary Share of not more 5 per cent. above the average middle market quotations for an Ordinary Share (as derived from the London Stock Exchange Daily Official List) for the five business days immediately preceding the date of repurchase.  It is possible that the price parameters for the Buy-Back may result in a price being paid that is greater than the higher of the last independent trade and the highest current independent bid from time-to-time.  \n \nShareholders should also be aware that, due to the generally low average daily trading volume, a repurchase of Ordinary Shares pursuant to the Buy-Back on any trading day may represent a significant proportion of the daily trad...

More updates from Ekf Diagnostics Holdings Plc